about
Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 updateGlycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells.Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft modelFunctional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective studyCidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrestExpression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significanceThe updated incidences and mortalities of major cancers in China, 2011microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1)Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivoBlocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells.Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts.A bird's eye view of the air pollution-cancer link in ChinaActivation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways.Pseudogene integrator complex subunit 6 pseudogene 1 (INTS6P1) as a novel plasma-based biomarker for hepatocellular carcinoma screening.The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.More than a virus: a qualitative study of the social implications of hepatitis B infection in China.Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.Liposomal curcumin and its application in cancer.Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma.The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance.Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms.
P2860
Q28079681-9BD2F41C-BCF6-4DFC-B9E3-9C390AC5CE80Q34690743-8D5688F7-FEA1-49DF-906C-33AFFC137F2EQ34729878-1DDD2B56-CFC1-4438-9468-527BB54EA339Q35051865-AE67B60A-5838-4283-A8BF-160C97AFF261Q35178728-2AC35D60-921A-4B8A-821C-6086731BB067Q35754179-9C64CC00-28A7-477B-834F-8C1139C6AE52Q36095161-DFB3267B-BB9E-459D-A7DD-AC62B00F3A56Q36121142-81B415B5-10FE-46B6-892D-10F5250FCFF0Q36250621-E53BAEDC-A546-43B5-8B07-8C0FC95E1797Q37305848-5A01178B-BB5B-4BA1-93A1-D710EB3E488FQ37420812-671B7880-96C1-44BE-9129-F49F3021C1F2Q37559079-6FC9D79A-5139-4A62-9CF2-A8E50370AB64Q37683697-61549EB2-5F48-4FE9-80D4-23EB1AF56E76Q38824920-60BBC600-D4DF-4C76-B21C-56307186CA35Q38842696-B94C2EA2-E77E-4261-813C-4E988A30E918Q38895583-E66FF554-82BC-40DD-9EC1-27CC6D3A7B55Q38904143-AE961AFB-0611-49F1-9D98-08A20BECF52FQ38948202-3E77135F-17B7-44E5-8B73-16397A3B4853Q40099139-2EA065FD-4492-4A49-BE38-35F29EE4B658Q41151007-DFB6AA39-0066-4353-9EB3-4E23A7B2A045Q41531940-25B84CAD-7D1B-4391-B428-75406F0F736AQ43202777-6B60B91A-B612-4A7A-BD24-92E189C99224Q46629915-3C68D756-2F94-42CC-A7A9-161C4D88F25BQ51048228-AB9D2ADE-C4CD-428D-B7CE-50CE91932E16Q51703634-8BD51F6D-A9D5-4C04-9475-711A190804B7Q54215487-A0AB0EF4-75D5-4274-8C39-B81B805C90D1Q54957789-5796AEAA-EAB4-4D52-A1DE-FB23DA9331F0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver cancer incidence and mortality in China, 2009
@en
Liver cancer incidence and mortality in China, 2009.
@nl
type
label
Liver cancer incidence and mortality in China, 2009
@en
Liver cancer incidence and mortality in China, 2009.
@nl
prefLabel
Liver cancer incidence and mortality in China, 2009
@en
Liver cancer incidence and mortality in China, 2009.
@nl
P2093
P2860
P356
P1476
Liver cancer incidence and mortality in China, 2009
@en
P2093
Rong-Shou Zheng
Si-Wei Zhang
Wan-Qing Chen
P2860
P304
P356
10.5732/CJC.013.10027
P577
2013-03-15T00:00:00Z